---
title: "Agitation Psychopharmacology"
output:
  html_document:
    toc: FALSE
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE)
library(tidyverse)
library(kableExtra)
```

**[Download Flashcards](flashcards/agitation_psychopharmacology.apkg)** for Anki

```{r, echo = FALSE}
# create data table of agitation information
df_agitate = data.frame(
  generic = c("Risperidone", "Olanzapine", "Haloperidol", "Lorazepam", "Lorazepam", "Ziprasidone", "Ziprasidone", "Olanzapine", "Aripiprazole", "Haloperidol", "Haloperidol"),
  route = c("PO", "PO", "PO", "PO", "IM", "IM", "IM", "IM", "IM", "IM", "IV"),
  brand = paste0(c("Risperdal", "Zyprexa", "Haldol", "Ativan", "Ativan", "Geodon", "Geodon", "Zyprexa", "Abilify", "Haldol", "Haldol"),"<sup>®</sup>"),
  dose_mg_0_ll = c(2, 5, 5, 2, 2, 10, 20, 5, 9.75, 5, 2),
  dose_mg_0_ul = c(2, 10, 5, 2, 2, 10, 20, 10, 9.75, 5, 5),
  t_hr_max_ll = c(1, 6, 0.5, 1/3, 1/3, 0.25, 0.25, 0.25, 1, 0.5, 0),
  t_hr_max_ul = c(1, 6, 1, 0.5, 0.5, 0.25, 0.25, 0.75, 1, 1, 0),
  t_hr_rep = c(2, 2, 0.25, 2, 2, 2, 4, 1/3, 2, .25, 4),
  dose_mg_max_day = c(6, 20, 20, 12, 12, 40, 40, 30, 30, 20, 10)
)
```

```{r, echo=F}
# format table for printing
df_agitate_pretty <- df_agitate %>% 
  mutate(
    # make time units as minutes
    across(starts_with("t_hr"), ~ .x*60),
    # limit digits to 2 decimals
    across(where(is.numeric), round, 2),
    # make single name of generic name and drug route
    generic = paste0(generic, " (", route, ")"),
    # if numbers have ranges, show them as ranges, otherwise just once
    dose_mg_0 = case_when(
      dose_mg_0_ll == dose_mg_0_ul ~ as.character(dose_mg_0_ll),
      dose_mg_0_ll != dose_mg_0_ul ~ paste0(dose_mg_0_ll, " – ", dose_mg_0_ul)
      ),
    t_hr_max = case_when(
      t_hr_max_ll == t_hr_max_ul ~ as.character(t_hr_max_ll),
      t_hr_max_ll != t_hr_max_ul ~ paste0(t_hr_max_ll, " – ", t_hr_max_ul)
      )
    # only include pretty variables
    ) %>% select(generic, brand, dose_mg_0, t_hr_max, t_hr_rep, dose_mg_max_day)

# add footnote symbols to row names
df_agitate_pretty$generic[c(3,10,11)] <- paste0(df_agitate_pretty$generic[c(3,10,11)],footnote_marker_symbol(1))
df_agitate_pretty$generic[c(11)] <- paste0(df_agitate_pretty$generic[c(11)],footnote_marker_symbol(2))

# name variables for printing
names(df_agitate_pretty) = c("Generic (Route)", "Brand", "Initial Dose (mg)", "Time to Max Concentration (min)", "Time Before Repeat Administration (min)", "Max Total Daily Dose (mg)")

# print html table
df_agitate_pretty %>% kbl(escape = F, align=c(rep('l', 2), rep('c', 4))) %>% kable_styling() %>% 
  footnote(symbol = c(
    "Likely to cause higher incidence of extrapyramidal side effects than other recommended drugs",
    "Administering haloperidol intravenously increases risk of QT prolongation. Avoid if possible, especially in patients w/ borderline QT or taking other medication that can prolong QT. If given IV, limit dose and provide cardiac monitoring."
    ))
```

```{r}
# format data for plotting
df_agitate_plot <- df_agitate %>% 
  mutate(
    generic = factor(generic, c("Haloperidol", "Lorazepam", "Olanzapine", "Ziprasidone", "Risperidone", "Aripiprazole")),
    route = factor(route, c("PO", "IM", "IV"), c("Oral (PO)", "Intramuscular (IM)", "Intravenous (IV)"))
  )

# custom theme
dg_theme <- cowplot::theme_cowplot() + theme(
  panel.border=element_rect(colour = "grey", fill=NA, linewidth=0.5, linetype = 3),
  strip.background=element_blank(),
  axis.title.y=element_blank(),
  axis.text.x=element_text(angle = 40, vjust=1.2, hjust=1.1, size=9),
  panel.spacing=unit(1,"lines")
  )

# axis labels
xlab_dose <- xlab(label = "Dose (mg)")
xlab_time <- xlab(label = "Time (hours)")

# base plot
gg_agitate_plot <- df_agitate_plot %>% 
  ggplot(aes(y=generic, yend=generic)) +
  scale_y_discrete(limits=rev) +
  scale_x_continuous(limits = c(0, NA), expand = c(0, NA), labels = ~ sprintf("%.1f", .x)) +
  # facet_grid(cols = vars(route)) +
  facet_grid(. ~ route, scales="free") +
  dg_theme

# size of dots
size_dots <- 2
```

## Dosing {.tabset}

### Composite

```{r}
gg_agitate_plot +
  # initial dose
  geom_segment(aes(x=dose_mg_0_ll, xend = dose_mg_0_ul)) +
  geom_point(aes(x = dose_mg_0_ll), size = size_dots, shape=3) +
  geom_point(aes(x = dose_mg_0_ul), size = size_dots, shape=3) +
  # max daily dose
  geom_point(aes(x = dose_mg_max_day), size=size_dots, shape=1) +
  xlab_dose
```

### + Initial Dose

```{r}
gg_agitate_plot +
  geom_segment(aes(x=dose_mg_0_ll, xend = dose_mg_0_ul)) +
  geom_point(aes(x = dose_mg_0_ll), size = size_dots, shape=3) +
  geom_point(aes(x = dose_mg_0_ul), size = size_dots, shape=3) +
  xlab_dose
```

### ○ Max Total Daily Dose

```{r}
gg_agitate_plot + geom_point(aes(x = dose_mg_max_day), size=size_dots, shape=1) + xlab_dose
```

## Timing {.tabset}

### Composite

```{r}
gg_agitate_plot +
  # time to max concentration
  geom_segment(aes(x=t_hr_max_ll, xend = t_hr_max_ul)) +
  geom_point(aes(x = t_hr_max_ll), size = size_dots, shape=3) +
  geom_point(aes(x = t_hr_max_ul), size = size_dots, shape=3) +
  # time before repeat administration
  geom_point(aes(x = t_hr_rep), size = size_dots, shape=1) +
  xlab_time
```

### + Time to Max Concentration

```{r}
gg_agitate_plot +
  geom_segment(aes(x=t_hr_max_ll, xend = t_hr_max_ul)) +
  geom_point(aes(x = t_hr_max_ll), size = size_dots, shape=3) +
  geom_point(aes(x = t_hr_max_ul), size = size_dots, shape=3) +
  xlab_time
```

### ○ Time Before Repeat Administration

```{r}
gg_agitate_plot + geom_point(aes(x = t_hr_rep), size = size_dots, shape=1) + xlab_time
```


<!-- | Generic         | Brand                  | Route               | Initial Dose | T<sub>max</sub> | Repeat                     | Maximum Daily Dose | Note                                                                                                                                                                                                                                                        | -->
<!-- | --------------- | ---------------------- | ------------------- | ------------- | --------------- | -------------------------- | -------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -->
<!-- | Risperidone PO  | Risperdal<sup>®</sup>  | Oral                | 2 mg          | 1 hr            | 2 hr                       | 6 mg / 24 hr   |                                                                                                                                                                                                                                                             | -->
<!-- | Olanzapine PO   | Zyprexa<sup>®</sup>    | Oral                | 5–10 mg       | 6 hr            | 2 hr                       | 20 mg / 24 hr  |                                                                                                                                                                                                                                                             | -->
<!-- | Haloperidol PO  | Haldol<sup>®</sup>     | Oral                | 5 mg          | 30–60 min       | 15 min                     | 20 mg / 24 hr  | Likely to cause higher incidence of extrapyramidal side effects than other recommended drugs                                                                                                                                                                | -->
<!-- | Lorazepam       | Ativan<sup>®</sup>     | Oral, Intramuscular | 2 mg          | 20–30 min       | 2 hr                       | 12 mg / 24 hr  |                                                                                                                                                                                                                                                             | -->
<!-- | Ziprasidone IM  | Geodon<sup>®</sup>     | Intramuscular       | 10–20 mg      | 15 min          | 10 mg q2 hr<br><br>20 mg q4 hr | 40 mg / 24 hr  |                                                                                                                                                                                                                                                             | -->
<!-- | Olanzapine IM | Zyprexa<sup>®</sup> | Intramuscular       | 5–10 mg       | 15–45 min       | 20 min                     | 30 mg / 24 hr  |                                                                                                                                                                                                                                                             | -->
<!-- | Aripiprazole IM | Abilify<sup>®</sup>    | Intramuscular       | 9.75 mg       | 1 hr            | 2 hr                       | 30 mg / 24 hr  |                                                                                                                                                                                                                                                             | -->
<!-- | Haloperidol IM  | Haldol<sup>®</sup>     | Intramuscular       | 5 mg          | 30–60 min       | 15 min                     | 20 mg / 24 hr  | Likely to cause higher incidence of extrapyramidal side effects than other recommended drugs                                                                                                                                                                | -->
<!-- | Haloperidol IV  | Haldol<sup>®</sup>     | Intravenous         | 2–5 mg        | Immediate       | 4 hr                       | 10 mg / 24 hr  | Administering haloperidol intravenously increases risk of QT prolongation.<br><br>Avoid if possible, especially in patients w/ borderline QT or taking other medication that can prolong QT.<br><br>If given IV, limit dose and provide cardiac monitoring. | -->


<p style="clear:both;"><hr></p>
<img src="images/agitation_psychopharmacology.png" width=100% align=right></img>
<p style="clear:both;"><hr></p>

## References

* Wilson, M. P. <a href="https://doi.org/10.5811/westjem.2011.9.6866">The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup</a> (2012)

* Benajah, N. <a href="https://unsplash.com/photos/mans-face-with-white-scarf-5_gku5Usbzk">Man’s Face with White Scarf</a> (2020)
